Kesler Norman & Wride LLC Buys 9,013 Shares of Stryker Corporation $SYK

Kesler Norman & Wride LLC lifted its stake in Stryker Corporation (NYSE:SYK) by 103.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 17,704 shares of the medical technology company’s stock after acquiring an additional 9,013 shares during the period. Kesler Norman & Wride LLC’s holdings in Stryker were worth $6,222,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. Bridges Investment Management Inc. lifted its stake in shares of Stryker by 16.0% in the fourth quarter. Bridges Investment Management Inc. now owns 144,689 shares of the medical technology company’s stock valued at $50,854,000 after buying an additional 19,983 shares during the period. Calton & Associates Inc. lifted its stake in shares of Stryker by 10.8% in the fourth quarter. Calton & Associates Inc. now owns 665 shares of the medical technology company’s stock valued at $234,000 after buying an additional 65 shares during the period. Tidemark LLC raised its position in Stryker by 1,475.0% in the fourth quarter. Tidemark LLC now owns 126 shares of the medical technology company’s stock worth $44,000 after purchasing an additional 118 shares in the last quarter. Dynasty Wealth Management LLC raised its position in Stryker by 3.6% in the fourth quarter. Dynasty Wealth Management LLC now owns 5,211 shares of the medical technology company’s stock worth $1,831,000 after purchasing an additional 182 shares in the last quarter. Finally, Beto Financial Group LLC acquired a new position in Stryker in the fourth quarter worth about $298,000. Institutional investors own 77.09% of the company’s stock.

Stryker Stock Performance

NYSE SYK opened at $293.36 on Wednesday. The firm has a market cap of $112.46 billion, a price-to-earnings ratio of 33.95, a PEG ratio of 1.89 and a beta of 0.78. The company has a 50 day moving average of $321.00 and a 200-day moving average of $347.64. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 1-year low of $281.00 and a 1-year high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the business posted $2.84 EPS. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Stryker in a research report on Friday, May 1st. Canaccord Genuity Group dropped their price target on shares of Stryker from $435.00 to $400.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Citigroup dropped their price target on shares of Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research report on Tuesday, April 7th. William Blair reissued an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Finally, Wells Fargo & Company dropped their price target on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Sixteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, Stryker has an average rating of “Moderate Buy” and an average target price of $395.48.

Insider Activity at Stryker

In related news, VP M Kathryn Fink sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.45, for a total value of $992,075.00. Following the completion of the sale, the vice president owned 177 shares of the company’s stock, valued at $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Ronda E. Stryker sold 310,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares of the company’s stock, valued at approximately $601,005,282.40. This represents a 13.87% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 323,264 shares of company stock valued at $100,659,489 over the last quarter. Corporate insiders own 4.60% of the company’s stock.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.